disappointed

Quote

anonymous

Guest
I have to admit, I’m disappointed by some of the comments in this thread. From my perspective as a member of the field team, this doesn’t reflect the sentiment I’ve experienced across our group.

While every organization has areas for improvement, I’ve seen a strong commitment to supporting life-changing therapies and prioritizing patient outcomes. I’ve also worked alongside colleagues who genuinely care about making a difference and strive to contribute meaningfully every day.

I believe constructive conversations can help us all grow and improve, but it’s also important to acknowledge the good work being done by so many on the team. Whoever is reading these posts, do not let the comments of a disgruntled few, ruin it for the rest of us. Travere is a solid, innovative company with great people on the ground.
 






Field Medical is pissing away its MSL team with goals and metrics that make zero sense for a medical affairs team. Running it like a sales team with metrics and competitive intelligence insights is a compliance issue. The problem is.. there is no compliance. Zero.
 






  • Debt Repurchase:
    Travere intended to use a portion of the net proceeds from a convertible senior notes offering to repurchase approximately $207.1 million aggregate principal amount of its outstanding 2.50% senior convertible notes due 2025, including accrued and unpaid interest, of approximately $213.8 million.
    This place has a cash runway of 24 months at Best.
 







Write your reply...
Top Bottom
Back
Quote